Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 28, 2018Estriol USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0490-2018Class IITerminatedFeb 28, 2018Estradiol Hemihydrate USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0489-2018Class IITerminatedFeb 28, 2018Estradiol USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0488-2018Class IITerminatedFeb 28, 2018Duloxetine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0487-2018Class IITerminatedFeb 28, 2018Doxycycline Hyclate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0486-2018Class IITerminatedFeb 28, 2018Diphenhydramine HCl USP fCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0485-2018Class IITerminatedFeb 28, 2018Diclofenac Sodium USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0484-2018Class IITerminatedFeb 28, 2018Desoximetasone USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0483-2018Class IITerminatedFeb 28, 2018Cyclosporine USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0482-2018Class IITerminatedFeb 28, 2018Cyclobenzaprine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0481-2018Class IITerminatedFeb 28, 2018Clonidine HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0480-2018Class IITerminatedFeb 28, 2018Clindamycin Phosphate USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0479-2018Class IITerminatedFeb 28, 2018Celecoxib USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0478-2018Class IITerminatedFeb 28, 2018Calcipotriene BPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0477-2018Class IITerminatedFeb 28, 2018Baclofen USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0476-2018Class IITerminatedFeb 28, 2018Anastrozole USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0475-2018Class IITerminatedFeb 28, 2018Amitriptyline HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0474-2018Class IIITerminatedFeb 28, 2018Calcium Acetate CapsulesPresence of Foreign Tablets/CapsulesNostrum Laboratories Inc · D-0473-2018Class IITerminatedFeb 28, 2018Nicardipine HCl in 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0469-2018Class IITerminatedFeb 28, 2018Dexamethasone Sodium Phosphate added to 5% Dextrose in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0468-2018Class IITerminatedFeb 28, 2018Rocuronium Bromide in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0467-2018Class IITerminatedFeb 28, 2018Methadone HCl Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0466-2018Class IITerminatedFeb 28, 2018Meperidine HCl in 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0465-2018Class IITerminatedFeb 28, 2018Esmolol HCl in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0464-2018Class IITerminatedFeb 28, 2018Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0463-2018Class IITerminatedFeb 28, 2018Vecuronium Bromide in Sterile Water for Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0462-2018Class IITerminatedFeb 28, 2018Neostigmine Methylsulfate Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0461-2018Class IITerminatedFeb 28, 2018Labetalol HCl in 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0460-2018Class IITerminatedFeb 28, 2018Nicardipine HCl in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0459-2018Class IITerminatedFeb 28, 2018Ropivacaine HCl Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0458-2018Class IITerminatedFeb 28, 2018HYDROmorphone HCl in 5% Dextrose in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0457-2018Class IITerminatedFeb 28, 2018Atropine Sulfate Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0456-2018Class IITerminatedFeb 28, 2018Lidocaine HCl in 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0455-2018Class IITerminatedFeb 28, 2018Glycopyrrolate in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0454-2018Class IITerminatedFeb 28, 2018Ropivacaine HCl in 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0453-2018Class IITerminatedFeb 28, 2018Ketamine HCl Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0452-2018Class IITerminatedFeb 28, 2018Ephedrine Sulfate Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0451-2018Class IITerminatedFeb 28, 2018Fentanyl Citrate Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0450-2018Class IITerminatedFeb 28, 2018Midazolam HCl Injection in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0449-2018Class IITerminatedFeb 28, 2018Methadone HCl in 0.9% Sodium Chloride in all strengthsLack of sterility assurance.Pharmedium Services, LLC · D-0448-2018